Association of Digoxin With Interstage Mortality: Results From the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Use Dataset
BackgroundMortality for infants with single ventricle congenital heart disease remains as high as 8% to 12% during the interstage period, the time between discharge after the Norwood procedure and before the stage II palliation. The objective of our study was to determine the association between dig...
Main Authors: | Matthew E. Oster, Michael Kelleman, Courtney McCracken, Richard G. Ohye, William T. Mahle |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.115.002566 |
Similar Items
-
Association of Digoxin Use With Transplant‐Free Interstage Survival in Infants Palliated With a Stage 1 Hybrid Procedure
by: Reshma K. Reddy, et al.
Published: (2023-10-01) -
Association of Digoxin With Preserved Echocardiographic Indices in the Interstage Period: A Possible Mechanism to Explain Improved Survival?
by: Maria Batsis, et al.
Published: (2021-12-01) -
Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
by: Kevin Y. Chang, et al.
Published: (2023-03-01) -
Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
by: Antonella Colella, et al.
Published: (2022-06-01) -
Incidence and Timing of Thrombosis After the Norwood Procedure in the Single‐Ventricle Reconstruction Trial
by: Michael H. White, et al.
Published: (2020-12-01)